Jordi Rodón Ahnert, MD, PhD

Articles by Jordi Rodón Ahnert, MD, PhD
Sacituzumab Tirumotecan for Gastric Cancer With TROP2 expression: The KL264-01 Trial
Jordi Rodón Ahnert, MD, PhDGastric Cancer | March 13, 2025
Dr. Rodón Ahnert compares the differences of sacituzumab tirumotecan use in the second- vs third-line setting for patients.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |